Science

MUNICH (Reuters) – Roche’s entrectinib cancer pill was shown to shrink tumors in 57 percent of patients within a group that can only be identified via genetic profiling, as the Swiss drugmaker challenges an alliance of Bayer and Loxo Oncology in a new targeted treatment area. FILE PHOTO: The logo of Swiss pharmaceutical company Roche
0 Comments
ZURICH/MUNICH (Reuters) – An immunotherapy cocktail from Roche helped slow an aggressive type of breast cancer where new treatments have proven elusive, offering positive news for the Swiss drugmaker as it chases medicines produced by its rivals. FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel January 30,
0 Comments
TOKYO (Reuters) – A European-Japanese spacecraft set off on a treacherous seven-year journey to Mercury to probe the solar system’s smallest and least-explored planet. FILE PHOTO: The spacecraft BepiColombo is seen at the European Space Agency’s (ESA) European Space Research and Technology Centre (ESTEC) in Noordwijk, Netherlands July 6, 2017. REUTERS/Michael Kooren The BepiColombo mission,
0 Comments
LONDON, Oct 17 (Reuters) – A respected science journal is to withdraw a much-cited review of evidence on an illness known as chronic fatigue syndrome (CFS) amid fierce criticism and pressure from activists and patients. The decision, described by the scientists involved as “disproportionate and poorly justified”, is being seen as a victory for activists
0 Comments